Status:
TERMINATED
KCNQ1 Cascade Screening
Lead Sponsor:
University of Maryland, Baltimore
Collaborating Sponsors:
National Human Genome Research Institute (NHGRI)
Conditions:
Long QT Syndrome
Eligibility:
All Genders
Phase:
NA
Brief Summary
The objectives of the protocol are to: (1) evaluate the uptake of cascade screening and preventative therapies after the implementation of a simplified screening process and (2) assess proband and fam...
Eligibility Criteria
Inclusion
- KCNQ1Thr224Met proband or first degree family member
Exclusion
- Family members who have not been contacted by probands
Key Trial Info
Start Date :
March 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 29 2022
Estimated Enrollment :
131 Patients enrolled
Trial Details
Trial ID
NCT03783975
Start Date
March 7 2019
End Date
December 29 2022
Last Update
June 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Maryland Amish Research Clinic
Lancaster, Pennsylvania, United States, 17602